Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W D Bloomer

Showing results (61-70 of 106) with videos related to

Pageof 11
Sort By:
Gynecologic Oncology|December 1, 1980
Stage II endometrial carcinoma: 10-year follow-up of combined radiation and surgical treatmentT J Kinsella, W D Bloomer, P T Lavin, et al.
Breast Cancer Research and Treatment|April 1, 1988
Animal modeling of human breast tumors: limitations in the use of estrogen pellet implantsR D Blumenthal, J J Jordan, W H McLaughlin, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 1981
Primary radiation therapy for early breast cancer: the experience at The Joint Center for Radiation TherapyJ R Harris, L Botnick, W D Bloomer, et al.
In Vivo (Athens, Greece)|November 7, 2001
In vitro evaluation of 4-[3-(2-nitro-1-imidazolyl)-propylamino]-7-trifluoromethylquinoline hydrochloride (NLTQ-1), a new bioreductive agent as a hypoxia marker by 19F-magnetic resonance spectroscopy (19F-MRS)M V Papadopoulou, R Pouremad, M K Rao, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 1979
Parasternal lymphoscintigraphy: implications for the treatment planning of internal mammary lymph nodes in breast cancerC M Rose, W D Kaplan, A Marck, et al.
Gynecologic Oncology|February 1, 1980
Stage III adenocarcinoma of the endometrium: two prognostic groupsJ E Bruckman, W D Bloomer, A Marck, et al.
The Mount Sinai Journal of Medicine, New York|September 1, 1988
Neuroendocrine abnormalities and the pathogenesis of estrogen-receptor-positive breast cancerS Lehrer, R R Brown, C Lee, et al.
Nuclear Medicine and Biology|February 1, 1994
A novel method for the non-chromatographic purification of technetium-99m-labeled monoclonal antibodies: a study with B72.3 monoclonal antibodyH S Rosenzweig, G N Ranadive, T Seskey, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|July 1, 1997
Dosimetric analysis and clinical implementation of 6 MV X-ray radiosurgery beamS G Prasad, K Parthasaradhi, C Des Rosiers, et al.
The British Journal of Radiology|February 1, 1981
Mediastinal lymphoscintigraphy in ovarian cancer using intraperitoneal autologous technetium-99m-labelled erythrocytesW D Kaplan, W D Bloomer, A G Jones, et al.
Pageof 11

Showing results (61-70 of 106) with videos related to

Sort By:
Pageof 11
Gynecologic Oncology|December 1, 1980
Stage II endometrial carcinoma: 10-year follow-up of combined radiation and surgical treatmentT J Kinsella, W D Bloomer, P T Lavin, et al.
Breast Cancer Research and Treatment|April 1, 1988
Animal modeling of human breast tumors: limitations in the use of estrogen pellet implantsR D Blumenthal, J J Jordan, W H McLaughlin, et al.
International Journal of Radiation Oncology, Biology, Physics|November 1, 1981
Primary radiation therapy for early breast cancer: the experience at The Joint Center for Radiation TherapyJ R Harris, L Botnick, W D Bloomer, et al.
In Vivo (Athens, Greece)|November 7, 2001
In vitro evaluation of 4-[3-(2-nitro-1-imidazolyl)-propylamino]-7-trifluoromethylquinoline hydrochloride (NLTQ-1), a new bioreductive agent as a hypoxia marker by 19F-magnetic resonance spectroscopy (19F-MRS)M V Papadopoulou, R Pouremad, M K Rao, et al.
International Journal of Radiation Oncology, Biology, Physics|October 1, 1979
Parasternal lymphoscintigraphy: implications for the treatment planning of internal mammary lymph nodes in breast cancerC M Rose, W D Kaplan, A Marck, et al.
Gynecologic Oncology|February 1, 1980
Stage III adenocarcinoma of the endometrium: two prognostic groupsJ E Bruckman, W D Bloomer, A Marck, et al.
The Mount Sinai Journal of Medicine, New York|September 1, 1988
Neuroendocrine abnormalities and the pathogenesis of estrogen-receptor-positive breast cancerS Lehrer, R R Brown, C Lee, et al.
Nuclear Medicine and Biology|February 1, 1994
A novel method for the non-chromatographic purification of technetium-99m-labeled monoclonal antibodies: a study with B72.3 monoclonal antibodyH S Rosenzweig, G N Ranadive, T Seskey, et al.
Medical Dosimetry : Official Journal of the American Association of Medical Dosimetrists|July 1, 1997
Dosimetric analysis and clinical implementation of 6 MV X-ray radiosurgery beamS G Prasad, K Parthasaradhi, C Des Rosiers, et al.
The British Journal of Radiology|February 1, 1981
Mediastinal lymphoscintigraphy in ovarian cancer using intraperitoneal autologous technetium-99m-labelled erythrocytesW D Kaplan, W D Bloomer, A G Jones, et al.
Pageof 11